Protalix BioTherapeutics, Inc. (PLX) has 44 open-market insider trades by 16 insiders since 2007. The most active filer is Frost Gamma Investments Trust, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Eli Hurvitz | Dir | — | 1 | $13.9M | 2009-11-12 |
| Ltd Bio-Cell | 10% | — | 1 | $10.9M | 2014-09-16 |
| Zeev Bronfeld | Dir | — | 1 | $10.9M | 2014-10-02 |
| Frost Gamma Investments Trust | 10% | — | 10 | $9.5M | 2009-08-28 |
| Camber Capital Management LLC | 10% Owner | — | 2 | $4.8M | 2016-12-02 |
| Phillip Md Et Al Frost | 10% | — | 6 | $4.3M | 2009-09-10 |
| Dan Oren | 10% Owner | — | 1 | $4.2M | 2021-06-03 |
| Alfred Akirov | Dir | — | 4 | $903K | 2013-08-15 |
| Aharon Schwartz | Dir | — | 3 | $518K | 2025-09-03 |
| Dror Bashan | CEOPres | — | 3 | $362K | 2025-12-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Dror Bashan | CEO & President | Buy | $101K | 2025-12-19 |
| Amos Bar-Shalev | Director | Sell | $314 | 2025-11-18 |
| Aharon Schwartz | Director | Buy | $206K | 2025-06-10 |
| Dror Bashan | CEO & President | Buy | $158K | 2023-10-19 |
| Aharon Schwartz | Director | Buy | $156K | 2023-01-03 |
| Dror Bashan | CEO & President | Buy | $102K | 2022-04-11 |
Companies that share insiders with PLX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Dan Oren | 10% Owner | Sell | $4.2M | 2021-06-02 |
| Aharon Schwartz | Director | Buy | $156K | 2020-04-07 |
| Moshe Manor | President | Buy | $41K | 2017-05-16 |
| Camber Capital Management LLC | 10% Owner | Sell | $800K | 2016-12-02 |
| Yossi Maimon | President & VP | Buy | $8K | 2015-12-14 |
| Camber Capital Management LLC | 10% | Buy | $4.0M | 2015-10-19 |
| Zeev Bronfeld | Director & 10% | Sell | $10.9M | 2014-08-13 |
| Alfred Akirov | Director | Sell | $568K | 2013-08-14 |
| Alfred Akirov | Director | Sell | $57K | 2013-03-12 |